These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients. Darcy DG; Chiaroni-Clarke R; Murphy JM; Honeyman JN; Bhanot U; LaQuaglia MP; Simon SM Oncotarget; 2015 Jan; 6(2):755-70. PubMed ID: 25605237 [TBL] [Abstract][Full Text] [Related]
24. Surgical Debulking for Refractory Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma. Solipuram V; Baretti M; Kim AY; Chen LX; Fahrner JA; Gunay-Aygun M; Peng XP; Hardenbergh D; Ferguson A; Griffith P; Wang Y; Brancati M; Gopalakrishna H; Kato T; Shubert C; Laheru D; Yarchoan M Hepatology; 2021 Nov; 74(5):2899-2901. PubMed ID: 34105830 [No Abstract] [Full Text] [Related]
25. Fibrolamellar Carcinoma: What Is New and Why It Matters. Graham RP Surg Pathol Clin; 2018 Jun; 11(2):377-387. PubMed ID: 29751881 [TBL] [Abstract][Full Text] [Related]
26. Acquired ornithine transcarbamylase deficiency in pediatric and adolescent patients with fibrolamellar hepatocellular carcinoma. Bartlett AL; Leslie ND; Gupta A; Geller JI Pediatr Blood Cancer; 2018 Dec; 65(12):e27392. PubMed ID: 30094907 [TBL] [Abstract][Full Text] [Related]
27. Molecular profiling and analysis of genetic aberrations aimed at identifying potential therapeutic targets in fibrolamellar carcinoma of the liver. El Dika I; Bowman AS; Berger MF; Capanu M; Chou JF; Benayed R; Zehir A; Shia J; O'Reilly EM; Klimstra DS; Solit DB; Abou-Alfa GK Cancer; 2020 Sep; 126(18):4126-4135. PubMed ID: 32663328 [TBL] [Abstract][Full Text] [Related]
28. mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma. Riehle KJ; Yeh MM; Yu JJ; Kenerson HL; Harris WP; Park JO; Yeung RS Mod Pathol; 2015 Jan; 28(1):103-10. PubMed ID: 24925055 [TBL] [Abstract][Full Text] [Related]
29. FGFR1 and FGFR2 in fibrolamellar carcinoma. Graham RP; Garcia JJ; Greipp PT; Barr Fritcher EG; Kipp BR; Torbenson MS Histopathology; 2016 Apr; 68(5):686-92. PubMed ID: 26259677 [TBL] [Abstract][Full Text] [Related]
31. Hepatocellular Carcinoma of Fibrolamellar Type in an Adolescent: Case Report and Literature Review. Santiago-Reynoso J; Zamaripa-Martínez KS; Dorantes-Loya JM; Gaytán-Fernández GJ; Apolinar-Jiménez E; Paz-Gómez F; Farias-Serratos F; Maldonado-Vega M Gastrointest Tumors; 2019 Aug; 6(1-2):43-50. PubMed ID: 31602376 [TBL] [Abstract][Full Text] [Related]
32. Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma. Levin SN; Tomasini MD; Knox J; Shirani M; Shebl B; Requena D; Clark J; Heissel S; Alwaseem H; Surjan R; Lahasky R; Molina H; Torbenson MS; Lyons B; Migler RD; Coffino P; Simon SM Sci Adv; 2023 Jun; 9(25):eadg7038. PubMed ID: 37343102 [TBL] [Abstract][Full Text] [Related]
33. Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy. Suarez O; Perez M; Garzon M; Daza R; Hernandez G; Salinas C; Ceballos J; de Leon EP; Mugnier J; Beltrán O; Varón A Case Reports Hepatol; 2018; 2018():7521986. PubMed ID: 30631612 [TBL] [Abstract][Full Text] [Related]
34. Non coding RNA analysis in fibrolamellar hepatocellular carcinoma. Farber BA; Lalazar G; Simon EP; Hammond WJ; Requena D; Bhanot UK; La Quaglia MP; Simon SM Oncotarget; 2018 Feb; 9(12):10211-10227. PubMed ID: 29535801 [TBL] [Abstract][Full Text] [Related]
35. Fibrolamellar carcinoma: A histologically unique tumor with unique molecular findings. Graham RP; Torbenson MS Semin Diagn Pathol; 2017 Mar; 34(2):146-152. PubMed ID: 28110996 [TBL] [Abstract][Full Text] [Related]
36. Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiency. Chan JS; Harding CO; Blanke CD South Med J; 2008 May; 101(5):543-5. PubMed ID: 18414167 [TBL] [Abstract][Full Text] [Related]
37. The Use of Fluorescence Weiel JJ; Forgo B; Sage J; Rangaswami A; Hazard FK Ann Clin Lab Sci; 2022 May; 52(3):475-483. PubMed ID: 35777788 [TBL] [Abstract][Full Text] [Related]
38. [76-year-old patient with adenocarcinoma of the rectum and fibrolamellar hepatocellular 2d carcinoma. Case report with literature review of hepatocellular carcinoma of the fibrolamellar type]. Klimpfinger M; Jatzko G; Trink A; Samec HJ; Gaugg A Wien Klin Wochenschr; 1987 Jul; 99(14):505-9. PubMed ID: 2820156 [TBL] [Abstract][Full Text] [Related]
39. Hyperammonemic Encephalopathy Exacerbated by Parenteral Nutrition in Fibrolamellar Hepatocellular Carcinoma. Shah PA; Cho J; Albitar HAH; Pajot G; Liu M; Ravi K Am J Med; 2020 Dec; 133(12):e745-e746. PubMed ID: 32739410 [No Abstract] [Full Text] [Related]
40. Hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency due to a novel combined heterozygous mutations. Gao J; Gao F; Hong F; Yu H; Jiang P Am J Emerg Med; 2015 Mar; 33(3):474.e1-3. PubMed ID: 25227973 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]